These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29599372)

  • 21. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.
    Odrazka K; Petera J; Kohlova T; Dolezel M; Vaculikova M; Zouhar M; Malek V; Hobza V; Latr I; Nemecek S; Sercl M; Ryska P; Blaha M; Cermakova E
    Strahlenther Onkol; 2003 Sep; 179(9):615-9. PubMed ID: 14628127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure.
    Canalese J; Gimson AE; Davis C; Mellon PJ; Davis M; Williams R
    Gut; 1982 Jul; 23(7):625-9. PubMed ID: 6806155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effects of topical dexamethasone on experimental brain tumours and peritumoural brain oedema.
    Ikeda Y; Carson BS; Long DM
    Acta Neurochir Suppl (Wien); 1990; 51():163-4. PubMed ID: 2089885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy.
    Oberndorfer S; Piribauer M; Marosi C; Lahrmann H; Hitzenberger P; Grisold W
    J Neurooncol; 2005 May; 72(3):255-60. PubMed ID: 15937649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
    Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
    J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
    Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects?
    Hempen C; Weiss E; Hess CF
    Support Care Cancer; 2002 May; 10(4):322-8. PubMed ID: 12029432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.
    Brandes AA; Franceschi E; Tosoni A; Blatt V; Pession A; Tallini G; Bertorelle R; Bartolini S; Calbucci F; Andreoli A; Frezza G; Leonardi M; Spagnolli F; Ermani M
    J Clin Oncol; 2008 May; 26(13):2192-7. PubMed ID: 18445844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas.
    Ludwig HC; Feiz-Erfan I; Bockermann V; Behnke-Mursch J; Schallock K; Markakis E
    Anticancer Res; 2000; 20(1A):299-304. PubMed ID: 10769671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical control trial of methylprednisolone and dexamethasone in treatment of intracranial tumor edema].
    Ding X; Mao B; Ju Y; Liu Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):327-9. PubMed ID: 12947730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interventional effect of new drugs combined with the Stupp protocol on glioblastoma: A network meta-analysis.
    Li M; Song X; Zhu J; Fu A; Li J; Chen T
    Clin Neurol Neurosurg; 2017 Aug; 159():6-12. PubMed ID: 28514722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of sequential vs. combined radiochemotherapy with temozolomide, resection and MGMT promoter hypermethylation on survival of patients with primary glioblastoma--a single centre retrospective study.
    Rapp M; Goeppert M; Felsberg J; Steiger HJ; Sabel M
    Br J Neurosurg; 2013 Aug; 27(4):430-5. PubMed ID: 23418781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
    Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
    J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients.
    Mineo JF; Bordron A; Baroncini M; Ramirez C; Maurage CA; Blond S; Dam-Hieu P
    Acta Neurochir (Wien); 2007 Mar; 149(3):245-52; discussion 252-3. PubMed ID: 17273889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aquaporin-4 contributes to the resolution of peritumoural brain oedema in human glioblastoma multiforme after combined chemotherapy and radiotherapy.
    Nico B; Mangieri D; Tamma R; Longo V; Annese T; Crivellato E; Pollo B; Maderna E; Ribatti D; Salmaggi A
    Eur J Cancer; 2009 Dec; 45(18):3315-25. PubMed ID: 19836227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.
    Athanassiou H; Synodinou M; Maragoudakis E; Paraskevaidis M; Verigos C; Misailidou D; Antonadou D; Saris G; Beroukas K; Karageorgis P
    J Clin Oncol; 2005 Apr; 23(10):2372-7. PubMed ID: 15800329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma.
    Chamberlain MC; Glantz MJ; Chalmers L; Van Horn A; Sloan AE
    J Neurooncol; 2007 Mar; 82(1):81-3. PubMed ID: 16944309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review.
    Dixit S; Hingorani M; Achawal S; Scott I
    Br J Neurosurg; 2011 Aug; 25(4):459-69. PubMed ID: 21344976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma.
    Kocher M; Frommolt P; Borberg SK; Rühl U; Steingräber M; Niewald M; Staar S; Stuschke M; Becker G; Fischedick AR; Herfarth K; Grauthoff H; Müller RP
    Strahlenther Onkol; 2008 Nov; 184(11):572-9. PubMed ID: 19016015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.